Population Pharmacokinetic Study and Individual Dose Adjustments of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma-Reference-Cited by-同舟云学术

Population Pharmacokinetic Study and Individual Dose Adjustments of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma

Published:2018-12-17 Issue:4 Volume:59 Page:566-577
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Hui Ka Ho¹^ORCID,Chu Ho Man¹,Fong Pui Shan¹,Cheng Wai Tsoi Frankie²³,Lam Tai Ning¹^ORCID

Affiliation:

1. School of Pharmacy; Faculty of Medicine; The Chinese University of Hong Kong; Hong Kong

2. Division of Haematology; Oncology, and Bone Marrow Transplantation; Department of Paediatrics; Prince of Wales Hospital; Hong Kong

3. Department of Paediatrics; The Chinese University of Hong Kong; Hong Kong

Funder

Research Grants Council, University Grants Committee

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.1349/fullpdf

Reference51 articles.

1. Antineoplastic drugs: clinical pharmacology and therapeutic use;Bender;Drugs,1978

2. Methotrexate: clinical pharmacology, current status and therapeutic guidelines;Cancer Treat Rev,1977

3. The pharmacology and clinical use of methotrexate;Jolivet;N Engl J Med,1983

4. The rationale for preoperative chemotherapy and delayed surgery;Rosen;Cancer,1979

5. Concepts in use of high-dose methotrexate therapy;Treon;Clin Chem,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model;Pharmaceutics;2024-09-06

2. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

3. Analysis of factors affecting the clinical efficacy and quality of life in the treatment of pediatric acute lymphoblastic leukemia;Pakistan Journal of Medical Sciences;2024-03-18

4. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review;European Journal of Clinical Pharmacology;2024-03-18

5. High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study;British Journal of Haematology;2024-03-03